| The latest advances in beta-lactam/beta-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections |
22 |
| Current and emerging treatment options for endometriosis |
18 |
| Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review |
18 |
| Current and emerging medical therapeutic agents for idiopathic male infertility |
16 |
| Safety and effectiveness of istradefylline in patients with Parkinson's disease: interim analysis of a post-marketing surveillance study in Japan |
15 |
| Innovative therapies for neovascular age-related macular degeneration |
14 |
| Current and emerging medications for the treatment of leishmaniasis |
14 |
| Advances in the treatment of HIV/HCV coinfection in adults |
13 |
| Current pharmacotherapies for sarcopenia |
12 |
| Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage |
12 |
| Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients |
12 |
| Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss |
11 |
| Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review |
11 |
| Istradefylline for the treatment of Parkinson's disease: is it a promising strategy? |
11 |
| Ixazomib for the treatment of multiple myeloma |
11 |
| Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species |
11 |
| Combatting resistant enterococcal infections: a pharmacotherapy review |
11 |
| Pharmacotherapy for onychomycosis: new and emerging treatments |
10 |
| Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas |
10 |
| Preventing and treating kidney disease in patients with type 2 diabetes |
10 |
| Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid |
10 |
| An evaluation of benznidazole as a Chagas disease therapeutic |
10 |
| Nintedanib for the treatment of idiopathic pulmonary fibrosis |
9 |
| State of the art opioid-sparing strategies for post-operative pain in adult surgical patients |
9 |
| Effects of the selective estrogen receptor modulators for the treatment of male infertility: a systematic review and meta-analysis |
9 |
| Making sleep easier: pharmacological interventions for insomnia |
9 |
| An evaluation of the pharmacotherapy for interstitial cystitis |
9 |
| Evaluating the novel application of cyclosporine 0.1% in ocular surface disease |
9 |
| Topoisomerase II inhibitors in AML: past, present, and future |
9 |
| Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study |
9 |
| Current pharmacotherapeutic options for primary dyslipidemia in adults |
8 |
| Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study |
8 |
| An update and systematic review on drug therapies for the treatment of refractory chronic cough |
8 |
| Current and emerging two-drug approaches for HIV-1 therapy in ART-naive and ART-experienced, virologically suppressed patients |
8 |
| An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy |
7 |
| Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes |
7 |
| Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence |
7 |
| The use of polymyxins to treat carbapenem resistant infections in neonates and children |
7 |
| Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema |
7 |
| Current pharmacotherapeutic options for myasthenia gravis |
7 |
| Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries |
7 |
| Improvement of endothelial function by pitavastatin: a meta-analysis |
7 |
| Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity |
7 |
| Pharmacotherapy for chronic non-specific low back pain: current and future options |
7 |
| Cilostazol for treatment of cerebral infarction |
7 |
| Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives |
6 |
| Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives |
6 |
| Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database |
6 |
| An evaluation of tedizolid for the treatment of MRSA infections |
6 |
| Ceftobiprole medocaril for the treatment of community-acquired pneumonia |
6 |
